Light-based therapies have been established for various indications, such as skin conditions, cancer or neonatal jaundice. Advances in the field of optogenetics open up new horizons for light-tissue interactions with an organism-wide impact. Excitable tissues, such as nerve and muscle tissues, can be controlled by light after the introduction of light-sensitive ion channels. Since these organs are generally not easily accessible to illumination in vivo, there is an increasing need for effective biocompatible waveguides for light delivery. These devices not only have to guide and distribute the light as desired with minimal losses, they should also mimic the mechanical properties of the surrounding tissue to ensure compatibility. In this project, we are tuning the properties of hydrogels from poly(ethylene glycol) derivatives to achieve compatibility with muscle tissue as well as optimal light guiding and distribution for optogenetic applications at the heart. The excitation light is coupled into the hydrogel with a biocompatible fiber. Properties of the hydrogel are mainly tuned by monomer length and concentration. Total reflection can be achieved by embedding a fiber-like hydrogel with a high refractive index into a second, low refractive index gel. Different geometries and scattering microparticles are used for light distribution in a flat gel patch. Targeted cell attachment can be achieved by introducing a protein layer to the otherwise bioinert gel. After optimization, the hydrogel may be used to deliver light for the excitation of genetically altered cardiomyocytes for controlled contraction.
INTRODUCTION

Optogenetics
Since the identification of light-driven ion channels in bacteria and algae, a new toolbox has been developed in biology. By introducing channels such as Channelrhodopsin-2 (ChR-2, an unspecific cation channel) or halorhodopsin (NpHR, permeable for chloride ions) to nerve or muscle cells, it is possible to control their membrane potential via light stimuli, thereby evoking a neuronal response or a contraction. The unprecedented spatio-temporal resolution of this stimulation method has already proven itself a valuable tool in basic research [1] [2] [3] . In vivo studies are already testing the versatility and robustness of optogenetics in living organisms 4, 5 , paving the way for novel optical therapies that are more gentle and precise than their current counterparts which rely on electrical stimulation.
Cardiac arrhythmia and cardioversion
In the healthy heart, the excitation stimulus is conducted along specialized paths and quickly distributed to the muscle tissue. This coordination of excitation allows for synchronized contraction of all parts of the heart, and therefore efficient blood ejection. Subsequently, the whole heart is in a refractory state and cannot be excited for a period of approx. 300 ms. Specialized pacemaker cells in the heart's sinus node determine the rhythm of contraction. Failure of these pacemaker cells or disturbances in the conduction paths can cause re-entry cycles -excitation is conducted in twirls, reentering some areas while others are still refractory. Consequently, the heart muscle does not contract as one but in uncoordinated patches. This results in a dramatically reduced ejection volume, a sudden drop of blood pressure, unconsciousness and, if proper blood flow cannot be restored quickly, death. The acute nature of this phenomenon makes it necessary for people at risk to wear an implantable cardioverter defibrillator (ICD), which detects arrhythmias in the patient's heart and triggers an electrical stimulus. This overrides the heart's own excitation cycles and resets the whole muscle to a refractory state, afterwards returning control to the sinus node. In the USA alone, about 800,000 patients live with an ICD 6 . Risk factors are congenital cardiac arrhythmias but also disturbances in conduction, which can occur after reperfusion following a heart attack. The process of defibrillation itself however poses considerable stress on the muscle tissue and the patient. The event is very painful, leaving some of those affected multiple times with clinical depression or post-traumatic stress disorders 7 . Moreover, the strong electrical shock can itself cause secondary injuries, further impairing correct conduction of excitation. Optical stimulation in combination with introduction of optogenetic channels to the tissue would greatly increase spatial resolution and have a largely reduced impact on the stimulated muscle cells.
Hydrogels as implantable waveguides
Therapies based on optogenetic methods can only be realized with the help of efficient light delivery into living tissues. The employed devices need to guide the stimulating light to the target tissue; a process that is complicated by strong scatter, instability of the immediate surroundings and the need for biocompatibility and possibly long term engraftment. Implantable devices such as µLED arrays or fibers already meet some of these requirements. While arrays from µLEDs are very flexible, engraftment of these devices into the target tissue is problematic. Biocompatible fibers are useful for spot illumination, but cannot be employed by themselves to target larger tissue areas. Light guiding hydrogels offer great versatility in their optical and mechanical properties [8] [9] [10] , can be engrafted into the target tissue 11 and are already in use for tissue engineering purposes 12 .
Hydrogel waveguides are already being tested in live tissues for applications such as sensing or phototherapies 9, 13 . In optogenetics, they could prove to be a valuable tool in distributing light to genetically manipulated tissues and enable simultaneous stimulation of a large number of cells.
Development of an implantable optical defibrillator
Combining the need for an alternative therapy for cardiac arrhythmia, the advances in optogenetics and the versatility of hydrogel waveguides, we are developing a novel device for optical cardioversion and defibrillation in a collaborative project. A biocompatible hydrogel shall distribute the light to transgenic engineered heart muscle tissue expressing ChR-2, acting as the starting point for the defibrillating stimulus. The feasibility of this approach has been tested and demonstrated before by ourselves (unpublished) as well as our partners 14, 15 . Now, we are aimed at advancing these methods to achieve a robust and reliable long term implant for painless cardioversion and defibrillation. In this paper, strategies for light distribution by hydrogels as well the control of the hydrogel-tissue-interface are described.
METHODS
Fabrication of hydrogels
Hydrogels were produced from poly(ethylene glycol) diacrylate (PEGDA, MW 700, Sigma Aldrich) or poly(ethylene glycol) dimethacrylate monomers (PEGDMA, MW 8000 or 20,000, Polysciences). The monomers were dissolved in water at the indicated concentration (all given as wt %). Microparticles were added where indicated (polystyrene particles from Kisker Biotech; TiO 2 particles, rutile, from Sigma Aldrich). Then, ammonium persulfate (10 % solution in H 2 O) and TEMED (both Millipore Sigma) were added at 1:100 or 1:1000, respectively. The mixtures were poured into the desired forms and radicalic polymerization occurred under a nitrogen atmosphere for 45-60 minutes. Gels were then stored in purified water until further use.
// '-:
Hydrogel measurements
Power losses were measured with a cut-back method: Inside a silicone mold, a hydrogel of 10 cm length with a diameter of 800 µm was produced. A green laser (λ = 532 nm) was coupled into this hydrogel fiber and the output power at the end of the hydrogel was measured. The gel was the shortened by 1 cm and power was measured again; this procedure was repeated until the end of the gel was reached. From input and output power, the damping coefficient was calculated.
Transmissivity was determined with a photometer. Three hydrogels per monomere were produced inside micro cuvettes and absorption and transmission were measured in the range of 300-1000 nm.
Refractive indices of hydrogel samples were measured with optical coherence tomography (central wavelength: 1325 nm; spectral bandwidth: 100 nm). Flat samples were produced as described above and placed onto a glass mirror. A B-scan of 3x3 mm was performed on the edge of the hydrogel, showing both the sample and the reflective mirror surface. The refractive index was calculated as the ratio of optical thickness (distance from upper to lower hydrogel surface) to actual thickness (distance from upper hydrogel surface to mirror surface). Three hydrogels per monomer length and concentration were produced, and three scans were performed per hydrogel.
Cell culture
HEK 293T cells were cultured according to a standard protocol in DMEM supplemented with 10 % FCS and 1 % penicillin/streptomycin (all PAN Biotech). To promote cell attachment on PEGDMA hydrogels, a 25 % PEGDMA 8000 gel containing polystyrene particles was produced, and a protein containing layer was added on top of the gel. For this layer, a 50 % PEGDMA 8000 solution was prepared and mixed with the same volume of cold matrigel (Corning), a mixture of extracellular matrix proteins. After protein addition, polymerization was quickly initialized as described above, and the whole solution was added on top of the pre-produced gel as a thin layer. After polymerization, the gel was immersed in cell culture medium and 6000 cells per mm 2 were seeded on the modified gel surface. For visualization, cells were stained with green fluorescing Calcein-AM.
Optical setup
Light distribution inside the hydrogels is assessed in a simple optical setup. Light from an interchangeable laser diode is coupled into a biocompatible fiber attached to the hydrogel sample. A sensitive CMOS camera is used for imaging from above (figure 2). Lenses can be interchanged to adjust spot size and image magnification. 
RESULTS AND DISCUSSION
Overall characteristics of PEGD(M)A hydrogels
Polymers from poly(ethylene glycol) di(meth)acrylate have tunable properties that vary with monomer length and concentration. The material is biocompatible and bioinert, providing an ideal basis for long term engraftment: the gels are not dissolved or remodeled by the cells' metabolistic activities, and the expected immunomodulation is mild 16 . Long term compatibility of a PEGDA implant on the cardiac muscle has already been demonstrated for regenerative purposes 11 . For the present application it is crucial that the implanted construct retains its overall shape for efficient waveguiding functionality. The PEG derivatives present a good starting point for a biohybrid permanent implant.
Flexibility with simultaneous stability is high for gels from long monomers (MW 8000 and 20,000 in this study), or shorter monomers at low concentrations. With decreasing monomer length and increasing monomer concentration, water content decreases and stiffness of the gels increases. Softness and flexibility are important considerations for successful in vivo engraftment. While quantitative measurements are yet to be done, monomers with a molecular weight of 8000 g/mol or more at concentrations of up to 50 % produce gels to generally match several soft tissues 8 .
Optical properties
Loss measurements yielded a damping coefficient of 0.78 dB/cm for a gel from PEGDA 700, 90 % at 532 nm. A short monomer at a high concentration is an unfavorable combination for efficient light delivery; with lower concentrations and larger monomers, power loss decreases 17 . However, since the engineered tissue patches are expected to be only a few centimeters in length, a loss of 50 % on a distance of 4 cm (corresponding to a damping coefficient of 0.78 dB/cm) is already tolerable. A power density of ~1 mW/mm 2 is required to trigger a photocurrent through ChR-2 18 . Current fibercoupled LED devices offer a power output of up to ~20 mW at the fiber tip 19 . In combination with a low-loss hydrogel waveguide, we expect to reach sufficient radiant exposures to excite cells in direct contact with the hydrogel. Aside from delivering light with high efficiency, functional electrical coupling in the engineered heart muscle tissue is crucial to achieve a wide spread response, strong enough to be passed on to the patient's heart tissue and terminate the fibrillation event. Since the quality of coupling varies, the necessary power output from the hydrogel will have to be determined experimentally.
Transmissivity and refractive index of the hydrogels is primarily dependent on their water content. Long monomers at low concentrations yield gels with a high water content. Transmissivity in most of the visual and the near infrared spectrum is high for these samples (figure 3), while the refractive index approaches the value of water. Tighter polymer a)
Laser diode (450 nm) hydrogel sample networks, i.e. from shorter monomers at higher concentrations, possess a higher refractive index. The gels tested during this work yielded values of up to 1.45. The differences in refractivity are sufficient to achieve total reflection in a gelwithin-gel construct (figure 4).
Since the radicalic polymerization reaction which forms the PEGD(M)A hydrogels never consumes all the acrylic head groups, the remaining groups are available to form covalent bonds to a second gel, polymerizing while in contact with the first gel. In this way, a single stable block of material can be manufactured in layers, which can be tuned to differ in their properties such as their refractive index. A fiber-shaped structure inside a gel block can be formed to guide light from a laser or a fiber on a fixed path through the hydrogel (figure 4). Different geometries can be explored to achieve controlled light distribution: bending of the inner hydrogel fiber causes the guided light to leave the fiber structure and propagate into the surrounding gel. Without adding any compounds or further derivatization PEGDA hydrogels allow for controlled light guiding and distribution. However, since modifying a gel's monomer composition also influences its stiffness and transmissivity, the architecture of the whole construct needs to take into account power losses and the hydrogel-tissue interface as well.
Light distribution
Waveguiding inside the hydrogels was observed from the top, perpendicular to the direction of fiber attachment (see figure 2b ). In the final construct, the light sensitive cells will reside on one flat side of the hydrogel. The light from the fiber should therefore be distributed across the whole area of only one side of the gel. In a simple hydrogel, the light spreads from the inserted fiber on a cone-shaped path and leaves the gel on the opposite side (figure 5a). Cells growing on top such a structure would not be efficiently stimulated. To improve overall light distribution, scattering microparticles were introduced to the hydrogel. Water soluble polystyrene particles were mixed into the PEGDMAsolution prior to polymerization and remained well dispersed after gelation. Light distribution in these gels is more favorable for this application as the scattering particles considerably improve light output from the gel's top side (figure 5b). While optimization of parameters like particle material, size and density is still ongoing, a combination of waveguiding based on changes in refractive index and scattering particles for even light distribution enables us to target a a) b)
PEGDMA 8000, 25 % PEGDA 700, 25 % Figure 3 : Relative transmission of PEGD(M)A gels in the UV/Vis spectrum. A longer monomer (i.e. a higher water content in the gel) yields gels with considerably higher transmissivity. These gels are favorable for light delivery in optogenetics, were the established variants of ChR-2 are excited at 470 nm (used in this project) or longer wavelengths of the visible spectrum. large number of cells immobilized on the hydrogel's surface. After optimization of the parameters to achieve the best light distribution in the gel construct, losses have to be reconsidered. Then, the proof of concept will be given by using the scattered light delivered through the hydrogel to evoke a contraction of transgenic heart muscle cells.
In a construct containing polystyrene particles, light is not directed to the upper surface, but scattered in all directions. The final design will be considerably thinner than the gels used for testing, so the lateral surfaces will be narrow. However, losses through the lower surface would be high. We therefore introduced a layer of titanium(IV) oxide (TiO 2 ) particles that possess strong backscattering properties and are insoluble in water. This causes the particles to settle to the ground of a forming hydrogel, producing a dense TiO 2 layer on the gel's lower surface. This layer effectively scatters the light reaching the bottom of the gel back into the construct, rendering the lower surface considerably darker when observed with the same exposure time as the upper side (figure 5c). For this layer it is especially important that particle distribution remains stable to avoid formation of holes and resulting losses. Long term observations under mechanical stresses mimicking the in vivo environment will be necessary to optimize hydrogel design and performance. One possibility to increase stability of the TiO 2 sheet is the addition of another gel on the bottom. Since this surface of the gel will not function as a substrate for cell growth, the mechanics have to be favorable for the construct as a whole, but do not need to match the heart muscle's properties. A stiffer gel, possibly even from a different material, might provide sufficient protection of the construct's functional units.
Cell attachment
PEGD(M)A hydrogels are bioinert and do not offer any features for cells to adhere to. To promote cell attachment at a controlled site, the gels have to be modified. Simple coating of the gels with proteins such as fibrin, collagen or matrigel, a mix of proteins from extracellular matrix, does not provide sufficient stability. Therefore, we exploit the radicalic polymerization reaction to tightly bind proteins to the hydrogel. A thin layer of PEGDMA solution mixed with liquid matrigel is applied on the particle containing gel construct. During polymerization, the PEGDMA molecules bind to the surface of the first gel as well as certain amino groups in the protein mix that are prone to radical formation. In this way, we obtain a PEGDMA layer with immobilized matrix protein, providing anchors for cells to attach to. Cells seeded on top of this protein containing gel can be successfully cultured on the construct, but do not migrate into the deeper layers (figure 6). While long term viability and stability is yet to be demonstrated, this is an easy and versatile method to control hydrogel-tissue interaction. The engineered tissue patch, consisting of matrigel, collagen, fibroblasts and cardiomyocytes, can be immobilized on the hydrogel in the same way. Therefore, the interface can be designed without introducing additional aberrations. 
CONCLUSION AND OUTLOOK
We demonstrate a first draft for a hydrogel waveguide for optogenetic applications at the heart muscle. A safe, robust and reliable long term implant will have to match tissue mechanics to ensure stable engraftment and deliver light at sufficient intensity to cells growing on the surface. PEGDMA hydrogels are easily tunable in their mechanical properties by varying monomer length and concentration. However, these parameters also determine the optical properties. A sophisticated layer-by-layer design enables us to achieve controlled waveguiding within the hydrogel while also providing a suitable surface for cell attachment. Introducing scattering microparticles is an easy method to improve light distribution towards the gel surface. Other possibilities to better control light guiding through the construct are internal changes in refractive index, as was demonstrated here as well, or two photon structuring of the hydrogel as has been shown before 20, 21 . Laser processing might hold potential for further improvement of our waveguide as well. While optimization and long term validation of the complete construct will take some time, the use of biocompatible, bioinert, modifiable hydrogels for light delivery in vivo is a versatile and promising approach to enable application of optogenetic methods or therapies in living organisms. 
